Results
1 -
8 of
8
(Click
here to explore results)
Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism, Chapter 3 Cholesterol and Alzheimer's Disease: The Molecules, the Targets . M. Dolores Ledesma, Carlos G. Dotti
, 2010
, Volume 1
, Pages 38-58
Animal Models for Neurodegenerative Disease, Chapter 7 Animal Models and the Pathogenesis of Parkinson's Disease . José G. Castaño, Teresa Iglesias, Justo G. de Yébenes
, 2011
, Pages 113-161
Electron Paramagnetic Resonance: Volume 19, Biomedical aspects of free radicals: Recent developments through the application of EPR . B. C. Gilbert, M. J. Davies, D. M. Murphy, Mark J. Burkitt
, 2004
, Volume 19
, Pages 33-81
Biological Interactions with Surface Charge in Biomaterials, Chapter 16 The Reduction of Restenosis in Cardiovascular Stents . J. Arkowski, M. Wawrzyńska, D. BiaŁy, B. Sobieszczańska, W. Mazurek
, 2012
, Pages 222-229
Gasotransmitters, Chapter 4 HO-1-derived CO Is a Regulator of Vascular Function and Metabolic Syndrome . J. Schragenheim, O. Maayan, N. G. Abraham
, 2018
, Pages 59-100
Polysaccharide-based Biomaterials: Delivery of Therapeutics and Biomedical Applications, Chapter 1 Polysaccharide-based Biomaterials: Overview . Sunil U. Tekale, Anant B. Kanagare, Anand V. Dhirbassi, Abraham J. Domb, Rajendra P. Pawar
, 2023
, Pages 1-26
Mass Spectrometry: Volume 7, The use of mass spectrometry in pharmacokinetic and drug-metabolism studies . R. A. W. Johnstone, D. J. Harvey
, 1984
, Volume 7
, Pages 293-352
Mass Spectrometry: Volume 9, Drug metabolism, pharmacokinetics, and toxicity . M. E. Rose, D. J. Harvey
, 1987
, Volume 9
, Pages 303-372